A long non-coding RNA called AK050834 drives vascular smooth muscle cell senescence by suppressing the anti-aging protein ATF3 while simultaneously stabilizing the pro-aging protein p21. Removing or blocking AK050834 prevents vascular aging in mice, suggesting a dual-target intervention point for age-related vascular disease.
Key Points
- AK050834 expression increases significantly with age in blood vessels
- AK050834 suppresses ATF3 and stabilizes p21, accelerating cellular aging
- AK050834 knockout prevents vascular aging in mice
Longevity Analysis
Vascular aging drives systemic aging and underlies most age-related diseases. This research identifies a single molecular switch that simultaneously manipulates two opposing aging regulators—one that protects against senescence and one that promotes it. Rather than requiring multiple drug targets, inhibiting AK050834 could theoretically reset the balance of these competing signals, offering a more efficient intervention than adding single-target therapies. The ability to decode what drives vascular cell senescence at the molecular level opens a pathway to prevent rather than manage age-related vascular dysfunction.
Original published by Wiley Aging Cell, by Haoran Wu, Ping Yang, Yang Liu, Qiuting Li, Xinglin Wang, Linyi Tang, Liyun Li, Ting Huang, Xin Zhang, Chunxiang Zhang .